Literature DB >> 19140011

Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit, H.T. Engelhardt, Jr. and J.R. Garrett (eds.) (Salem: M & M Scrivener Press, 2008).

Erica K Rangel1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19140011     DOI： 10.1007/s10730-008-9085-2

Source DB:  PubMed          Journal:  HEC Forum        ISSN： 0956-2737


× No keyword cloud information.
  4 in total

1.  Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit, H.T. Engelhardt, Jr. and J.R. Garrett (eds.) (Salem: M & M Scrivener Press, 2008).

Authors:  Erica K Rangel
Journal:  HEC Forum       Date:  2008-12

2.  Development of an integrated performance measurement (PM) model for pharmaceutical industry.

Authors:  Hosein Shabaninejad; Mohammad Hossein Mirsalehian; Gholamhossein Mehralian
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

3.  Considerations for applying bioethics norms to a biopharmaceutical industry setting.

Authors:  Luann E Van Campen; Tatjana Poplazarova; Donald G Therasse; Michael Turik
Journal:  BMC Med Ethics       Date:  2021-03-25       Impact factor: 2.652

4.  Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market.

Authors:  Hosein Shabaninejad; Gholamhossein Mehralian; Arash Rashidian; Ahmad Baratimarnani; Hamid Reza Rasekh
Journal:  Daru       Date:  2014-04-03       Impact factor: 3.117
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.